40B — HealthBank Holdings Income Statement
0.000.00%
Last trade - 00:00
- SG$7.92m
- SG$7.71m
- CNY0.23m
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.099 | 0.379 | 0.226 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -8.27 | -3.69 | 3.96 | 11.6 | 36.3 |
Operating Profit | 8.27 | 3.69 | -3.86 | -11.2 | -36.1 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.27 | 3.69 | -3.86 | -11.2 | -36.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.27 | 3.69 | -3.86 | -11.2 | -36.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -15.6 | -4.91 | -3.64 | -11.1 | -36 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -15.6 | -4.91 | -3.64 | -11.1 | -36 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.039 | -0.13 | -0.047 | -0.144 | -0.382 |